Pain & Central Nervous System Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pain & Central Nervous System Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Estrogen Replacement Therapy
Estrogen modulates cerebral angiogenic potential in middle-aged female rats
March 31st, 2003
Estrogen modulates cerebral angiogenic potential in middle-aged female rats. According to a study from Japan, "the effect of postmenopausal estrogen replacement therapy (ERT) on the risk or severity of cerebrovascular disorders is as yet unclear, and the evidence for flow preservation being a mechanism of estrogen neuroprotection remains elusive." "The authors examined whether estrogen-mediated flow-preserving neuroprotective mechanisms, if any, may involve its angiogenic action. This study was conducted using middle-aged (44 weeks) female rats because of the importance of aging in cerebrovascular disease in women," stated S. Jesmin and coauthors,...
Source: Pain & Central Nervous System Week (2003-03-31)
|
